Contact
searchSearch
HMP Global

Volume 18 - Issue 11 - November, 2006

Case Report

Use of a Thrombus Extraction Catheter (Pronto®) in the Treatment of Acute Myocardial Infarction after Coronary Embolism Post M
08/01/2008
Michael B. De Young, DO; Samer Kazziha, MD, FACP, FACC, FSCAI, FCCP
Coronary embolism is one of the less common causes of myocardial infarction. In this case, we describe a patient who sustained a myocardial infarction due to coronary embolism which was successfully treated using a thrombus aspiration device,...
Coronary embolism is one of the less common causes of myocardial infarction. In this case, we describe a patient who sustained a myocardial infarction due to coronary embolism which was successfully treated using a thrombus aspiration device,...
Coronary embolism is one of the...
08/01/2008
Journal of Invasive Cardiology
Case Report
Should the Left Main Be Covered Entirely with Drug-Eluting Stents in Percutaneous Intervention?
08/01/2008
Iñigo Lozano Martinez-Luengas, MD, PhD, FESC; Pablo Avanzas, MD, PhD, FESC; Cesar Moris, MD, PhD
Percutaneous coronary intervention (PCI) with balloon angioplasty or bare-metal stents are not adequate procedures in the treatment of the left main (LM) coronary artery disease because they are associated with an unacceptable restenosis...
Percutaneous coronary intervention (PCI) with balloon angioplasty or bare-metal stents are not adequate procedures in the treatment of the left main (LM) coronary artery disease because they are associated with an unacceptable restenosis...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
Case Report
Incomplete Stent Apposition in a Left Main Bifurcated Lesion after Kissing Stent Implantation
08/01/2008
Yoshinobu Murasato, MD, PhD; Hiroshi Suzuka, MD; Yoshiyuki Suzuki, MD
The introduction of drug-eluting stents in clinical practice has markedly lowered the incidence of coronary restenosis,1,2 although the management of bifurcation lesions remains challenging.3 The “kissing” stent technique, whereby stents...
The introduction of drug-eluting stents in clinical practice has markedly lowered the incidence of coronary restenosis,1,2 although the management of bifurcation lesions remains challenging.3 The “kissing” stent technique, whereby stents...
The introduction of drug-eluting...
08/01/2008
Journal of Invasive Cardiology
Case Report

Successful Percutaneous Revascularization of Circumflex Artery Injury after Minimally Invasive Mitral Valve Repair and Left At
08/01/2008
Evelio Rodriguez, MD; Michael J. Miller, MD; Jaffar Ali Raza, MD
Atrial fibrillation (AF) is commonly seen in patients with mitral regurgitation (MR). Mitral valve (MV) repair with simultaneous atrial ablation for the management of AF is the preferred method of treatment for MR associated with AF. There...
Atrial fibrillation (AF) is commonly seen in patients with mitral regurgitation (MR). Mitral valve (MV) repair with simultaneous atrial ablation for the management of AF is the preferred method of treatment for MR associated with AF. There...
Atrial fibrillation (AF) is...
08/01/2008
Journal of Invasive Cardiology
Letters to the Editor
The Steerable Guidewire: A Simple Method to Recross Deployed Stents
08/01/2008
Jack P. Chen, MD, FACC, FSCAI, FCCP
Recrossing a deployed stent with a guidewire is sometimes required when a distal lesion is recognized after wire withdrawal, or when a second “buddy wire” is required to facilitate distal advancement of another device. A popular technique is...
Recrossing a deployed stent with a guidewire is sometimes required when a distal lesion is recognized after wire withdrawal, or when a second “buddy wire” is required to facilitate distal advancement of another device. A popular technique is...
Recrossing a deployed stent with...
08/01/2008
Journal of Invasive Cardiology
Editorial Message
Nov-06
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers, This November 2006 issue of the Journal of Invasive Cardiology, which coincides with the 2006 American Heart Association (AHA) Annual Scientific Sessions held in Chicago, Illinois, includes original research articles,...
Dear Readers, This November 2006 issue of the Journal of Invasive Cardiology, which coincides with the 2006 American Heart Association (AHA) Annual Scientific Sessions held in Chicago, Illinois, includes original research articles,...
Dear Readers, This November...
08/01/2008
Journal of Invasive Cardiology
Case Report
Bifurcation Balloon for Left Main Shock Syndrome: Facilitating the Simultaneous Percutaneous Reperfusion of the LAD and Circumfl
08/01/2008
Ferdinand Kiemeneij, MD, PhD; Karen de Man, MD; Mark S. Patterson, MBBS, PhD, MD, MRCP
Acute thrombosis of the unprotected left main coronary artery (LMCA) produces cardiogenic shock (CS), or left main shock syndrome, in the majority of affected patients.1,2 The prognosis of the subset of patients that have complete (TIMI 0)...
Acute thrombosis of the unprotected left main coronary artery (LMCA) produces cardiogenic shock (CS), or left main shock syndrome, in the majority of affected patients.1,2 The prognosis of the subset of patients that have complete (TIMI 0)...
Acute thrombosis of the...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
Coronary Stent Malapposition as a Result of a Post-Stenotic Aneurysm Detected by Optical Coherence Tomography
08/01/2008
Ik-Kyung Jang, MD, PhD; Joseph C. Hannan, MD, FACC; O. Christopher Raffel, MD
An 82-year-old female with exertional dyspnea and a positive stress test underwent elective coronary angiography which revealed lesions in the left anterior descending coronary artery and right coronary artery (RCA). Staged percutaneous...
An 82-year-old female with exertional dyspnea and a positive stress test underwent elective coronary angiography which revealed lesions in the left anterior descending coronary artery and right coronary artery (RCA). Staged percutaneous...
An 82-year-old female with...
08/01/2008
Journal of Invasive Cardiology
Review
The Coronary Venous System: An Alternative Route of Access to the Myocardium
08/01/2008
Ajay K. Jain, MD, MBBS, MRCP; Elliot J. Smith, MD; Martin T. Rothman, FRCP, FACC, FESC
The epicardial coronary venous system has become the subject of renewed interest in recent years. There appear to be three main domains in which a thorough understanding of the venous system may lead to potentially useful clinical...
The epicardial coronary venous system has become the subject of renewed interest in recent years. There appear to be three main domains in which a thorough understanding of the venous system may lead to potentially useful clinical...
The epicardial coronary venous...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Intracoronary Transplantation of Autologous Bone Marrow Mesenchymal Stem Cells for Ischemic Cardiomyopathy Due to Isolated Chron
08/01/2008
Tak W. Kwan, MD, FACC; Shaoliang Chen, MD; Junjie Zhang, MD; Fei Yei, MD; Zhongsheng Zhu, MD; Song Lin, MD; Zhizhong Liu, MD; Nailiang Tian, MD; Baoxian Duan, MD
Myocardial infarction is the leading cause of congestive heart failure (CHF) and death in developed western countries and in China as well. The current pharmacotherapy for CHF includes neurohormonal inhibition with beta-blockers and...
Myocardial infarction is the leading cause of congestive heart failure (CHF) and death in developed western countries and in China as well. The current pharmacotherapy for CHF includes neurohormonal inhibition with beta-blockers and...
Myocardial infarction is the...
08/01/2008
Journal of Invasive Cardiology
Rapid Communication
Export Aspiration Catheter-Enhanced FilterWire‚Ñ¢ Delivery: An Innovative Strategy for Treatment of Saphenous Vein Graft Disease
08/01/2008
Wing-hing Chow, MBBS, FRCP; Hee-Hwa Ho, MD; Man-Hong Jim, MD
Percutaneous saphenous vein graft (SVG) intervention has a high incidence of distal embolization, usually in the range of 15–20%.1,2 The release of friable atherothrombotic materials causes the no-reflow phenomenon and myonecrosis, which are...
Percutaneous saphenous vein graft (SVG) intervention has a high incidence of distal embolization, usually in the range of 15–20%.1,2 The release of friable atherothrombotic materials causes the no-reflow phenomenon and myonecrosis, which are...
Percutaneous saphenous vein...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Predictors and Clinical Outcomes of Residual Shunt in Patients undergoing Percutaneous Transcatheter Closure of Patent Foramen O
08/01/2008
Alan Zajarias, MD; Srihari Thanigaraj, MD; John Lasala, MD, PhD, FACC, FACP; Julio Perez-Rodriguez, MD
A patent foramen ovale (PFO) can be identified in as many as 25% of the adult population.1 Though in the vast majority of cases the PFO is clinically silent, its presence is associated with serious and well-recognized complications. The...
A patent foramen ovale (PFO) can be identified in as many as 25% of the adult population.1 Though in the vast majority of cases the PFO is clinically silent, its presence is associated with serious and well-recognized complications. The...
A patent foramen ovale (PFO) can...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
COMMENTARY: The Trouble with Bubbles
08/01/2008
Steven L. Goldberg, MD
Why do residual shunts exist after patent foramen ovale (PFO) closure devices are placed? Possible explanations include the use of a device too small for the defect, inability of the placed device to adequately conform to the defect, leakage...
Why do residual shunts exist after patent foramen ovale (PFO) closure devices are placed? Possible explanations include the use of a device too small for the defect, inability of the placed device to adequately conform to the defect, leakage...
Why do residual shunts exist...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Early Revascularization and ACC/AHA Guideline-Compliant Medical Management Improve Left Ventricular Function and Short-Term Prog
08/01/2008
Santosh Menon, MD, FACC; Eugene S. Chung, MD; Theodore Chow, MD; Anubhav Mital, BS; Joseph Pastore, PhD; Dean J. Kereiakes, MD, FACC, MSCAI; John J. Young, MD
Early restoration of normal coronary perfusion after myocardial infarction (MI) limits infarct size, preserves left ventricular (LV) function and reduces mortality. The primary objective of reperfusion therapy is not only to restore...
Early restoration of normal coronary perfusion after myocardial infarction (MI) limits infarct size, preserves left ventricular (LV) function and reduces mortality. The primary objective of reperfusion therapy is not only to restore...
Early restoration of normal...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
High Left Ventricular Mass Index Does Not Limit the Utility of Fractional Flow Reserve for the Physiologic Assessment of Lesion
08/01/2008
Lawrence W. Gimple, MD; Christopher M. Kramer, MD; Joshua J. Fischer, MD; Kurt G. Barringhaus, MD; Habib Samady, MD; Michael Ragosta, MD; Eric R. Powers, MD; Alan J. Sarembock, MD; Adnan K. Chhatriwalla, MD
Myocardial fractional flow reserve (FFR) is an invasive index of the physiologic significance of a coronary stenosis. FFR is simply measured as the mean intracoronary pressure distal to a lesion divided by the mean aortic pressure during...
Myocardial fractional flow reserve (FFR) is an invasive index of the physiologic significance of a coronary stenosis. FFR is simply measured as the mean intracoronary pressure distal to a lesion divided by the mean aortic pressure during...
Myocardial fractional flow...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
COMMENTARY: Broadening the Applications of Fractional Flow Reserve
08/01/2008
Richard Callihan, MD; Tarek A. Helmy, MD
The concept of fractional flow reserve (FFR) was introduced by Pijls et al in his publication in 1993.1 This concept uses pressure measurement as a surrogate for flow, in a state where resistance is minimal and constant, a state of maximal...
The concept of fractional flow reserve (FFR) was introduced by Pijls et al in his publication in 1993.1 This concept uses pressure measurement as a surrogate for flow, in a state where resistance is minimal and constant, a state of maximal...
The concept of fractional flow...
08/01/2008
Journal of Invasive Cardiology
Simultaneous Restenosis of Taxus® and Cypher™ Drug-Eluting Stents
08/01/2008
Kent R. Nilsson, Jr., MD, FACC, MA, FHRS; Shayar M. Gharacholou, MD; Mitchell W. Krucoff, MD; Michael H. Sketch, Jr., MD
Case Presentation. A 55-year-old African-American male with a past medical history notable for coronary artery disease, insulin-dependent diabetes mellitus complicated by end-organ damage, hypertension and hyperlipidemia presented to our...
Case Presentation. A 55-year-old African-American male with a past medical history notable for coronary artery disease, insulin-dependent diabetes mellitus complicated by end-organ damage, hypertension and hyperlipidemia presented to our...
Case Presentation. A 55-year-old...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Clinical Experience with Rotational Atherectomy in Patients with Severe Left Ventricular Dysfunction
08/01/2008
Bruce E. Lewis, MD; Lowell H. Steen, MD; Ferdinand Leya, MD; Ravi K. Ramana, DO; Dominique Joyal, MD; Robert S. Dieter, MD, RVT; Dinesh Arab, MD
Over the past decade there have been tremendous advancements in the technique and procedural success rates in the field of interventional cardiology. Many of these advancements have addressed percutaneous coronary interventions (PCI) on...
Over the past decade there have been tremendous advancements in the technique and procedural success rates in the field of interventional cardiology. Many of these advancements have addressed percutaneous coronary interventions (PCI) on...
Over the past decade there have...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
COMMENTARY: Rotational Atherectomy Debulking in Depressed Left Ventricular Function: Just Do It
08/01/2008
On Topaz, MD, FACC
Percutaneous coronary intervention (PCI) in patients with depressed left ventricular function requires patience, technical skills and, at times, even a counterintuitive approach. In this high-risk group, standard PCI methods, mainly balloon...
Percutaneous coronary intervention (PCI) in patients with depressed left ventricular function requires patience, technical skills and, at times, even a counterintuitive approach. In this high-risk group, standard PCI methods, mainly balloon...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Bolus-Only Platelet Glycoprotein IIb/IIIa Inhibition During Percutaneous Coronary Intervention
08/01/2008
Reuven Lapin, PA-C, PA; Shyam Poludasu, MD; Jonathan D. Marmur, MD, FACC; Erdal Cavusoglu, MD; Pompeiu Vladutiu, MD; Ajay Agarwal, MD; Alan Feit, MD
Several large randomized clinical trials and meta-analyses have shown that inhibition of platelet aggregation with platelet glycoprotein IIb/IIIa inhibitors (GPI) improves outcomes in patients presenting with acute coronary syndromes and in...
Several large randomized clinical trials and meta-analyses have shown that inhibition of platelet aggregation with platelet glycoprotein IIb/IIIa inhibitors (GPI) improves outcomes in patients presenting with acute coronary syndromes and in...
Several large randomized...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
COMMENTARY: Bolus-Only Glycoprotein IIb/IIIa Inhibitor Revisited
08/01/2008
Abdolreza Agahtehrani, MD, PhD; George D. Dangas, MD, PhD
This paper has prospectively examined the efficacy of the use of bolus glycoprotein IIb/IIIa inhibitor (GPI) during percutaneous coronary intervention (PCI) in a single-arm registry. Both in-hospital outcomes and bleeding complications as...
This paper has prospectively examined the efficacy of the use of bolus glycoprotein IIb/IIIa inhibitor (GPI) during percutaneous coronary intervention (PCI) in a single-arm registry. Both in-hospital outcomes and bleeding complications as...
This paper has prospectively...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
The RADI™ PressureWire® High-Sensitivity Thermistor and Culprit Lesion Temperature in Patients with Acute Coronary Syndromes
08/01/2008
H.M. Omar Farouque, MBBS, PhD, MD; Mauro Baldi, BSc; Derek P. Chew, MBBS, MPH, PhD; Stephen G. Worthley, MBBS, PhD, MD, PhDH, MB, BS ; Matthew I. Worthley, MBBS, PhD; Ian T. Meredith, BSc, PhD, MBBS, FRACP, MD
The underlying pathobiology in most patients with acute coronary syndromes (ACS) is culprit lesion disruption with associated thrombosis.1 There is an increasing body of evidence showing that these culprit lesions, the so-called “vulnerable”...
The underlying pathobiology in most patients with acute coronary syndromes (ACS) is culprit lesion disruption with associated thrombosis.1 There is an increasing body of evidence showing that these culprit lesions, the so-called “vulnerable”...
The underlying pathobiology in...
08/01/2008
Journal of Invasive Cardiology

News

thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
AI Cardiac Imaging Software
Study Reveals Stark Disconnect Between Americans’ Desire for Preventive Cardiac Screening and Care They Can Access
01/27/2026
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to...
01/27/2026
Cath Lab Digest
Patent Foramen Ovale Detection
BURL Concepts Announces First Human Uses of FOQUS Ultrasound System for Patent Foramen Ovale (PFO) Detection
01/27/2026
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system,...
01/27/2026
Cath Lab Digest
AI Plaque analysis
Aetna Approves Coverage for Cleerly's AI Cardiovascular Imaging Analysis
01/21/2026
DENVER, CO – Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives,...
DENVER, CO – Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives,...
DENVER,...
01/21/2026
Cath Lab Digest
AI Plaque analysis
Coverage Unlocks Reimbursable AI Plaque Quantification With Circle Cardiovascular Imaging's cvi42|Plaque
01/21/2026
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its FDA 510(k)-cleared cvi42 with AI-enabled plaque...
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its FDA 510(k)-cleared cvi42 with AI-enabled plaque...
CALGARY, Alberta -- Circle...
01/21/2026
Cath Lab Digest
Acquisitions
Haemonetics Acquires Vivasure Medical Limited
01/21/2026
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite...
01/21/2026
Cath Lab Digest
Early CAD Detection
Mammograms and Hidden Heart Disease: Annual Scans Can Detect This Silent Killer and Help Save Lives, but Awareness Is Key
01/21/2026
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast...
01/21/2026
Cath Lab Digest
Radiation Protection Systems
Cathpax Demonstrates Ability to Offer Interventional Physicians Unmatched Level of Radiation Protection Thanks to First-of-Its-Kind NOVARAD Clinical Study
01/21/2026
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD...
01/21/2026
Cath Lab Digest
Technology & Health Literacy
ECRI: Misuse of AI Chatbots Tops Annual List of Health Tech Hazards
01/21/2026
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots...
01/21/2026
Cath Lab Digest
CAD Risk Factors
North Carolina State University Study Finds Police-Related Stress Associated With Physical Markers of Cardiovascular Health Risk for Black Women
01/19/2026
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related...
01/19/2026
Cath Lab Digest

Bangalore top 10
Author Interview
Editor’s 2025 Top 10: Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease
02/02/2026
Sripal Bangalore, MD, MHA; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, catches up with Dr Sripal Bangalore about his Editor’s 2025 Top 10 article, “Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease.”
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, catches up with Dr Sripal Bangalore about his Editor’s 2025 Top 10 article, “Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease.”
Dr Deepak L. Bhatt,...
02/02/2026
Journal of Invasive Cardiology
Editor's 2025 Top 10
Editor's Message
Editor’s 2025 Top 10
02/02/2026
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 Articles from 2025.
Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 Articles from 2025.
Dr Deepak L. Bhatt,...
02/02/2026
Journal of Invasive Cardiology
Original Contribution
Early Outcomes of the Myval Octacor Transcatheter Heart Valve in Transcatheter Aortic Valve Implantation: A Single-Center Study From Serbia
01/30/2026
Valentina Balint, MD; Mihajlo Farkic, MD; Jovan Petrovic, MD; Matija Furtula, MD; Milos D. Babic, MD; Dragan Topic, MD; Ida Subotic, MD; Vladimir Zobenica, MD; Alfonso Ielasi, MD; Luca Testa, MD, PhD; Milovan Bojic, MD, PhD; Aleksandra Nikolic, MD, PhD
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early...
01/30/2026
Journal of Invasive Cardiology
Sovari Figure 1
Clinical Videos
Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter
01/29/2026
Jeong Hwan J. Kim, MD; Leili Pourafkari, MD; Jonathan Lalezari, MD; Ali Sovari, MD
Video Supplement to "Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter" (Clinical Image).
Video Supplement to "Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter" (Clinical Image).
Video Supplement to "Right...
01/29/2026
Journal of Invasive Cardiology
Clinical Images
Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter
01/29/2026
Jeong Hwan J. Kim, MD; Leili Pourafkari, MD; Jonathan Lalezari, MD; Ali Sovari, MD
A 77-year-old man with peripheral arterial disease, sick sinus syndrome, hypertension, and paroxysmal atrial fibrillation (AF) presented for rhythm control. He had a normally functioning dual-chamber pacemaker but had frequent symptomatic AF...
A 77-year-old man with peripheral arterial disease, sick sinus syndrome, hypertension, and paroxysmal atrial fibrillation (AF) presented for rhythm control. He had a normally functioning dual-chamber pacemaker but had frequent symptomatic AF...
A 77-year-old man with...
01/29/2026
Journal of Invasive Cardiology
Clinical Images
Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker
01/28/2026
Nicolas Bradt, MD; Maxim Verlee, MD, PhD(c); Christophe Borin, MD; Hans Vandekerckhove, MD; Laurens De Vos, MD
A 51-year-old man with a mixed-phenotype cardiomyopathy was referred for coronary angiography because of new-onset episodes of ventricular arrythmias. At his initial presentation in 2014, he was diagnosed with hypertrophic cardiomyopathy,...
A 51-year-old man with a mixed-phenotype cardiomyopathy was referred for coronary angiography because of new-onset episodes of ventricular arrythmias. At his initial presentation in 2014, he was diagnosed with hypertrophic cardiomyopathy,...
A 51-year-old man with a...
01/28/2026
Journal of Invasive Cardiology
Bradt Figure
Clinical Videos
Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker
01/28/2026
Nicolas Bradt, MD; Maxim Verlee, MD, PhD(c); Christophe Borin, MD; Hans Vandekerckhove, MD; Laurens De Vos, MD
Video Supplement to "Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker" (Clinical Image).
Video Supplement to "Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker" (Clinical Image).
Video Supplement to "Septal...
01/28/2026
Journal of Invasive Cardiology
thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
Heart Failure Devices
CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
01/27/2026
The BENEFIT-HF trial is expected to be one of the largest therapeutic cardiac device trials ever performed in heart failure, randomizing 2,500 patients in approximately 150 centers in the United States and Germany. The primary endpoint will...
The BENEFIT-HF trial is expected to be one of the largest therapeutic cardiac device trials ever performed in heart failure, randomizing 2,500 patients in approximately 150 centers in the United States and Germany. The primary endpoint will...
The BENEFIT-HF trial is expected...
01/27/2026
Cath Lab Digest
HighLife TMVR
Mitral Valve Intervention
HighLife Receives CE Mark Approval for its Transcatheter Mitral Valve Replacement (TMVR) Solution
01/27/2026
Paris – HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received CE Mark approval for the HighLife Transcatheter Mitral Valve Replacement...
Paris – HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received CE Mark approval for the HighLife Transcatheter Mitral Valve Replacement...
Paris – HighLife SAS, a...
01/27/2026
Cath Lab Digest

November 2006 Volume 18 Issue 11

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use